Behavioral problems in dementia: Strategies for pharmacologic and nonpharmacologic management

Postgraduate Medicine

Volumn 115, Issue 6, 2004, Pages 47-56

  Smith, Amanda G ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE MESILATE; BUSPIRONE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; GALANTAMINE; HALOPERIDOL; HYPNOTIC AGENT; LEUPRORELIN; LORAZEPAM; MEDROXYPROGESTERONE ACETATE; MELATONIN; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; TEMAZEPAM; TRAZODONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZALEPLON; ZIPRASIDONE; ZOLPIDEM TARTRATE;

AGITATION; AGRANULOCYTOSIS; AKATHISIA; ALZHEIMER DISEASE; ANOREXIA; APATHY; ATAXIA; BEHAVIOR DISORDER; BRADYCARDIA; BRONCHOSPASM; CAREGIVER; CLINICAL FEATURE; CONFERENCE PAPER; CONFUSION; DELUSION; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DYSTONIA; ECG ABNORMALITY; FALLING; HALLUCINATION; HEADACHE; HIP FRACTURE; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPERTENSION; HYPONATREMIA; HYPOTENSION; LIVER TOXICITY; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; PAIN; PARKINSONISM; PHOTOSENSITIVITY DISORDER; PRIAPISM; RESTLESSNESS; SEDATION; SEXUAL DYSFUNCTION; SLEEP DISORDER; STANDING; TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN THROMBOSIS; WEIGHT GAIN;

EID: 2942550480     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2004.06.1536     Document Type: Conference Paper

References (15)

1. Tariot PN. Treatment of agitation in dementia. J Clin Psychiatry 1999;60(Suppl 8):11-20
2. Desai AK, Grossberg GT. Recognition and management of behavioral disturbances in dementia. Prim Care Companion J Clin Psychiatry 2001;3(3): 93-109
3. Ballard CG, O'Brien JT, Reichelt K, et al. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 2002;63(7):553-8
4. Mintzer JE. Managing behavioral dyscontrol related to dementia. Prim Care Companion J Clin Psychiatry 2003;5(Suppl 6):14-21
5. Kahn DA, Alexopoulos GS, Silver JM, et al. Treatment of agitation in elderly persons with dementia: a summary of the expert consensus guidelines. J Pract Psychiatry Behav Health 1998;5:265-76
6. Lantz MS. Options for the treatment of behavioral disturbances in dementia. Clin Geriatr 2003;11(1):34-6
7. Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001;158(6):892-8
8. Finkel SI. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry 2001;62(Suppl 21):3-6
9. Cummings JL, Vinters H, Felix J, eds. The neuropsychiatry of Alzheimer's disease and related dementias. London: Martin Ijunitz, 2003:16, 23-32, 57-103, 120-8, 281-99
10. Jones GM. A review of Feil's validation method for communicating with and caring for dementia sufferers. Curr Opin Psychiatry 1997;10(4):326-32
11. Wirshing DA, Danovitch I, Erhart SM, et al. Update on atypicals: practical tips to manage common side effects. Curr Psychiatry 2003;2(3):49-57
12. Lara DR, Cruz MR, Xavier F, et al. Allopurinol for the treatment of aggressive behaviour in patients with dementia. Int Clin Psychopharmacol 2003;18(1):53-5
13. Stewart JT. Dopaminergic treatment of restlessness and pacing in individuals with dementia. (Letter) Am J Geriatr Psychiatry 2001;9(4):445-6
14. Avorn J. Drug prescribing, drug taking, adverse reactions, and compliance in elderly patients. In: Salzman C, ed. Clinical geriatric psychopharmacology. 3rd ed. Baltimore: Williams & Wilkins, 1998:34-5
15. 14 pp 184-244